$697Million | No. of Holdings #74
Sio Capital Management, LLC Performance
| Ticker | $ Bought |
|---|---|
| corcept therapeutics inc | 27,199,500 |
| gsk plc | 21,296,700 |
| abbott laboratories | 19,155,600 |
| embecta corp | 16,335,000 |
| sionna therapeutics inc | 11,800,100 |
| monopar therapeutics inc | 9,506,390 |
| eyepoint inc | 9,303,810 |
| compass pathways plc | 8,331,080 |
| Ticker | % Inc. |
|---|---|
| cencora inc | 534 |
| abivax sa | 214 |
| vir biotechnology inc | 213 |
| ani pharmaceuticals inc | 204 |
| anteris technologies global | 187 |
| waystar hldg corp | 167 |
| icon plc | 140 |
| haemonetics corp mass | 138 |
| Ticker | % Reduced |
|---|---|
| zimmer biomet holdings inc | -83.76 |
| sanofi sa | -75.33 |
| organon & co | -74.69 |
| celcuity inc | -59.37 |
| neuroone med technologies co | -56.44 |
| hyperfine inc | -50.00 |
| context therapeutics inc | -31.58 |
| dianthus therapeutics inc | -22.01 |
| Ticker | $ Sold |
|---|---|
| xilio therapeutics inc | -1,366,530 |
| kenvue inc | -25,278,900 |
| ventyx biosciences inc | -3,501,390 |
| fulcrum therapeutics inc | -4,320,420 |
| brightspring health svcs inc | -11,535,000 |
| the cigna group | -47,395,400 |
| alkermes plc | -2,667,980 |
| ideaya biosciences inc | -2,617,990 |
Sio Capital Management, LLC has about 50.2% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 50.2 |
| Others | 42.7 |
| Industrials | 7.1 |
Sio Capital Management, LLC has about 9.7% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 38.1 |
| MID-CAP | 25 |
| SMALL-CAP | 20.5 |
| LARGE-CAP | 9.7 |
| MICRO-CAP | 5.6 |
About 45.1% of the stocks held by Sio Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 54.9 |
| RUSSELL 2000 | 39.9 |
| S&P 500 | 5.2 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
Sio Capital Management, LLC has 74 stocks in it's portfolio. About 45.1% of the portfolio is in top 10 stocks. ICLR proved to be the most loss making stock for the portfolio. was the most profitable stock for Sio Capital Management, LLC last quarter.
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
Cencora Inc Cencora IncABC Sio Capital Management, LLC's holding in Cencora Inc over time | 4.54% | 100,894 | $31.69M 4.54% | 534.55%increased 534.55 percentadded | |
Abbott Laboratories Sio Capital Management, LLC's holding in Abbott Laboratories over time | 2.75% | 186,574 | $19.16M 2.75% | Newnew position | |
Aligos Therapeutics Inc Sio Capital Management, LLC's holding in Aligos Therapeutics Inc over time | 0.35% | 327,237 | $2.43M 0.35% | 2.59%decreased 2.59 percentreduced | |
Alkermes Plc Alkermes PlcALKS Sio Capital Management, LLC's holding in Alkermes Plc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Ani Pharmaceuticals Inc Sio Capital Management, LLC's holding in Ani Pharmaceuticals Inc over time | 2.93% | 265,543 | $20.42M 2.93% | 204.27%increased 204.27 percentadded | |
An2 Therapeutics Inc Sio Capital Management, LLC's holding in An2 Therapeutics Inc over time | 0.32% | 657,200 | $2.25M 0.32% | Newnew position | |
Aquestive Therapeutics Inc Sio Capital Management, LLC's holding in Aquestive Therapeutics Inc over time | 1.14% | 1,922,890 | $7.98M 1.14% | 93.63%increased 93.63 percentadded | |
Avalo Therapeutics Inc Sio Capital Management, LLC's holding in Avalo Therapeutics Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Biomarin Pharmaceutical Inc Sio Capital Management, LLC's holding in Biomarin Pharmaceutical Inc over time | 1.57% | 194,226 | $10.97M 1.57% | 16.53%decreased 16.53 percentreduced | |
Cross Ctry Healthcare Inc Sio Capital Management, LLC's holding in Cross Ctry Healthcare Inc over time | 1.48% | 1,098,390 | $10.32M 1.48% | 2.77%increased 2.77 percentadded | |
Celcuity Inc Celcuity IncCELC Sio Capital Management, LLC's holding in Celcuity Inc over time | 3.17% | 193,843 | $22.13M 3.17% | 59.37%decreased 59.37 percentreduced | |
The Cigna Group Sio Capital Management, LLC's holding in The Cigna Group over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
CMPS Compass Pathways PlcCompass Pathways PlcCMPS | 1.2% | 1,506,520 | $8.33M 1.2% | Newnew position | |
Context Therapeutics Inc Sio Capital Management, LLC's holding in Context Therapeutics Inc over time | 0.34% | 917,922 | $2.40M 0.34% | 31.58%decreased 31.58 percentreduced | |
Corcept Therapeutics Inc Sio Capital Management, LLC's holding in Corcept Therapeutics Inc over time | 3.9% | 674,759 | $27.20M 3.9% | Newnew position | |
Charles Riv Labs Intl Inc Sio Capital Management, LLC's holding in Charles Riv Labs Intl Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Crinetics Pharmaceuticals In Sio Capital Management, LLC's holding in Crinetics Pharmaceuticals In over time | 1.3% | 249,887 | $9.08M 1.3% | 100.16%increased 100.16 percentadded | |
DRUG Bright Minds Biosciences IncBright Minds Biosciences IncDRUG | 0.9% | 86,083 | $6.28M 0.9% | 5.13%increased 5.13 percentadded | |
Embecta Corp Embecta CorpEMBC Sio Capital Management, LLC's holding in Embecta Corp over time | 2.34% | 1,847,850 | $16.34M 2.34% | Newnew position | |
Enanta Pharmaceuticals Inc Sio Capital Management, LLC's holding in Enanta Pharmaceuticals Inc over time | 0.07% | 40,000 | $505.2K 0.07% | 0%unchanged 0 percentunchanged | |